|
1
|
Warriner AH and Saag KG: Osteoporosis
diagnosis and medical treatment. Orthop Clin North Am. 44:125–135.
2013. View Article : Google Scholar
|
|
2
|
Mosekilde L, Vestergaard P and Rejnmark L:
The pathogenesis, treatment and prevention of osteoporosis in men.
Drugs. 73:15–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Bertulucci LA, Pereira FM, de Oliveira
AE, Brito LM and Lopes FF: Periodontal disease in women in
post-menopause and its relationship with osteoporosis. Rev Bras
Ginecol Obstet. 34:563–567. 2012.(In Portuguese).
|
|
4
|
Alania KN, Iverieli MB, Abashidze NO,
Gogishvili KhB and Chigladze TT: Oral cavity features in patients
suffering from osteogenesis imperfecta. Georgian Med News.
193:34–41. 2011.(In Russian).
|
|
5
|
Lippuner K: The future of osteoporosis
treatment - a research update. Swiss Med Wkly.
142:w136242012.PubMed/NCBI
|
|
6
|
Teti A: Bone development: overview of bone
cells and signaling. Curr Osteoporos Rep. 9:264–273. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blair HC, Schlesinger PH, Huang CL and
Zaidi M: Calcium signalling and calcium transport in bone disease.
Subcell Biochem. 45:539–562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao K, Nagashima K and Miki H:
Pharmacological, pharmacokinetic, and clinical properties of
benidipine hydrochloride, a novel, long-acting calcium channel
blocker. J Pharmacol Sci. 100:243–261. 2006. View Article : Google Scholar
|
|
9
|
Kosaka N and Uchii M: Effect of benidipine
hydrochloride, a dihydropyridine-type calcium antagonist, on the
function of mouse osteoblastic cells. Calcif Tissue Int.
62:554–556. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ducy P, Zhang R, Geoffroy V, Ridall AL and
Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast
differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakashima K, Zhou X, Kunkel G, et al: The
novel zinc finger-containing transcription factor osterix is
required for osteoblast differentiation and bone formation. Cell.
108:17–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Komori T, Yagi H, Nomura S, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ducy P, Starbuck M, Priemel M, et al: A
Cbfa1-dependent genetic pathway controls bone formation beyond
embryonic development. Genes Dev. 13:1025–1036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Neve A, Corrado A and Cantatore FP:
Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol.
228:1149–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsuji K, Bandyopadhyay A, Harfe BD, et al:
BMP2 activity, although dispensable for bone formation, is required
for the initiation of fracture healing. Nat Genet. 38:1424–1429.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beertsen W and Van den Bos T: Alkaline
phosphatase induces the deposition of calcified layers in relation
to dentin: an in vitro study to mimic the formation of afibrillar
acellular cementum. J Dent Res. 70:176–181. 1991. View Article : Google Scholar
|
|
17
|
Liu D, Zhang J, Wang G, Liu X, Wang S and
Yang M: The dual-effects of LaCl3 on the proliferation,
osteogenic differentiation, and mineralization of MC3T3-E1 cells.
Biol Trace Elem Res. 150:433–440. 2012.
|
|
18
|
Liu D, Zhang J, Li Y, Wang S and Yang M:
The effects of Ce on the proliferation, osteogenic differentiation
and mineralization function of MC3T3-E1 cells in vitro. Biol Trace
Elem Res. 149:291–297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishiya Y, Kosaka N, Uchii M and Sugimoto
S: A potent 1,4-dihydropyridine L-type calcium channel blocker,
benidipine, promotes osteoblast differentiation. Calcif Tissue Int.
70:30–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishiya Y and Sugimoto S: Effects of
various antihypertensive drugs on the function of osteoblast. Biol
Pharm Bull. 24:628–633. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimizu H, Nakagami H, Yasumasa N, Mariana
OK, Kyutoku M, Koriyama H, Nakagami F, Shimamura M, Rakugi H and
Morishita R: Links between hypertension and osteoporosis:
benidipine ameliorates osteoporosis in ovariectomized hypertensive
rats through promotion of osteoblast proliferation and inhibition
of osteoclast differentiation. Curr Cardiovasc Risk Rep. 6:274–280.
2012. View Article : Google Scholar
|
|
22
|
Yun HY, Yun MH, Kang W and Kwon KI:
Pharmacokinetics and pharmacodynamics of benidipine using a slow
receptor-binding model. J Clin Pharm Ther. 30:541–547. 2005.
View Article : Google Scholar : PubMed/NCBI
|
